M/Z: 665.4338

Hit 1 annotations: Paliperidone Palmitate_[M+H]+

在BioDeep NovoCell知识数据库中，参考离子总共被划分为4个级别。

Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
Unreliable: 这个参考离子具有较高的排名价值，但缺乏可重复性。
Unavailable: 由于排名价值低且缺乏可重复性，这个参考离子不应用于注释。

Found 3 Reference Ions Near m/z 665.4338

NovoCell ID	m/z	Mass Window	Metabolite	Ranking	Anatomy Context
MSI_000055631 Unreliable	665.4243	665.4242 ~ 665.425 MzDiff: `3.4 ppm`	Cyclopassifloside II (BioDeep_00000025426) Formula: C37H62O11 (682.4292)	1.76 (100%)	Homo sapiens [UBERON:0001043] esophagus
MSI_000055758 Unreliable	665.425	665.425 ~ 665.425 MzDiff: `none`	Cyclopassifloside II (BioDeep_00000025426) Formula: C37H62O11 (682.4292)	0.32 (100%)	Homo sapiens [UBERON:0007779] transudate
MSI_000057256 Unreliable	665.4338	665.4338 ~ 665.4338 MzDiff: `none`	Paliperidone Palmitate (BioDeep_00000182051) Formula: C39H57FN4O4 (664.4364)	1.24 (100%)	Homo sapiens [UBERON:0007779] transudate

Found 2 Sample Hits

Metabolite	Species	Sample
Paliperidone Palmitate Formula: C39H57FN4O4 (664.4364) Adducts: [M+H]+ (Ppm: 14.8)	Homo sapiens (esophagus)	LNTO22_1_4 Resolution: 17μm, 82x80 Description
m/z_665.4302 Formula: - (n/a) Adducts: (Ppm: 0)	Homo sapiens (colorectal adenocarcinoma)	80TopL, 50TopR, 70BottomL, 60BottomR-profile Resolution: 17μm, 137x136 Description The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

Metabolite

Species

Sample

Paliperidone Palmitate

Formula: C39H57FN4O4 (664.4364)
Adducts: [M+H]+ (Ppm: 14.8)

Homo sapiens (esophagus)

LNTO22_1_4

Resolution: 17μm, 82x80

Description

m/z_665.4302

Formula: - (n/a)
Adducts: (Ppm: 0)

Homo sapiens (colorectal adenocarcinoma)

80TopL, 50TopR, 70BottomL, 60BottomR-profile

Resolution: 17μm, 137x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).